Purchase Order 75N93024P01128
- Not listed
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The $12,866.00 contract is for mRNA sequencing services to support NIAID's biomedical research efforts. Novogene has established itself as a key provider of DNA and RNA sequencing, library preparation, and data analysis services to various federal agencies,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $11,820 firm fixed-price purchase order to Novogene Corporation Inc., a Sacramento, California-based minority-owned small business specializing in genomic sequencing and bioinformatics services. Awarded on September 9, 2021, with an ultimate completion date of September 28, 2022, this contract involved no small business set-aside. The award was issued to administratively de-obligate unexpended and expiring fiscal year...
- Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order contract valued at $24,350 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for laboratory testing services to support genomic sequencing and bioinformatics research efforts. Specifically, Novogene will provide DNA/RNA sample sequencing and data analysis services leveraging Illumina and PacBio platforms, including whole...
- This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian federal agency, to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for $21,800 and covers laboratory and testing services, specifically strand-specific mRNA sequencing and bioinformatics analysis, with a period of performance through March 31, 2026. Novogene has an established track record of providing advanced genomic sequencing...
- Novogene Corp Inc., a minority-owned small business, has been awarded a $13,982 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide RNA sequencing services in Bethesda, Maryland. The sequencing will support the agency's biomedical research efforts. As a prime contractor supporting multiple federal agencies, Novogene has over 100 contracts to conduct genomic sequencing and analysis for studies into diseases,...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $15,900.00 contract will provide plant and animal ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) services utilizing the Illumina NovaSeq PE150 platform. The work will be performed in Sacramento, California and is expected to be...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and task orders. This award is not associated with a set-aside program. Novogene's extensive work with agencies like the National Institutes of Health, Department of Agriculture, and U.S. Geological Survey demonstrates its capability to handle diverse research needs across the government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 9/11/24 |